Monday, May 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

USAMRIID Seeks Mouse Supply for Filovirus Research

by Global Biodefense Staff
December 22, 2015
USAMRIID Ebola Laboratory

A technician sets up an assay for Ebola within a containment laboratory. Samples are handled in negative-pressure biological safety cabinets to provide an additional layer of protection. Credit: U.S. Army photo by Dr. Randal J. Schoepp

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the Department of Defense’s lead laboratory for medical biological defense research, has announced a service contract opportunity to support filovirus research.

USAMRIID is attempting to find prospective businesses to provide a monthly supply of Type I interferon alpha/beta receptor knockout mice (IFNAR-/- mice) for the biodefense research projects.

The selected contractor must produce enough mice each month to supply USAMRIID with 150-300 mice between 4-8 weeks of age.

The period of performance will be one year with the option to extend services for up to 5 years.

Further details are available via Solicitation Number: W81XWH15KQ1210. The response deadline is Dec. 28, 2015.

Tags: EbolaMarburgRequest for Proposals

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
State Department: Reducing Revisionist State Biological and Chemical Weapons Threats
CBRNE

CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats

March 21, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC